Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.

This study has been completed.
Information provided by:
Radboud University Identifier:
First received: November 28, 2006
Last updated: August 23, 2010
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)